The funds are to help the health service prepare for a winter wave of coronavirus

The drug is considered a cost-effective treatment for relapsed or refractory FLT3 mutation-positive acute myeloid leukaemia

Animal testing has dipped to its lowest figure since 2007, but Animal Free Research UK has condemned the […]

The move is based on the first indication-seeking registry-based randomised controlled trial

FiercePharmaAsia—BeiGene’s $2.1B share sale; Harbour’s meaty C round; Lupin plant COVID-19 closure aliu Fri, 07/17/2020 – 08:44

AstraZeneca scores speedy FDA review for Farxiga based on ‘innovative’ heart attack trial design kblankenship Fri, 07/17/2020 – […]

J&J, Sanofi and more look to ink national COVID-19 vaccine supply pacts in EU, Japan: reports kblankenship Fri, […]

Sanofi to move ahead with complicated API spinoff worth up to €2B: Reuters esagonowsky Fri, 07/17/2020 – 11:15

Epileptic disorders can vary greatly in terms of type, cause and severity. This makes having accurate knowledge of […]

Department B for Internal Medicine of the University Medical Center Greifswald successfully used, within an international multi-center trial, […]